N-Acetyltryptamine

(Redirected from N-acetyltryptamine)

N-Acetyltryptamine is an organic compound with the molecular formula C12H14N2O. It is a partial agonist for the melatonin receptors.[2][3] N-Acetyltryptamine is produced by Streptomyces djakartensis and other Streptomyces and Fusarium species.[4][5]

N-Acetyltryptamine
Names
IUPAC name
N-[2-(1H-indol-3-yl)ethyl]acetamide[1]
Other names
Acetotryptamide
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
  • InChI=1S/C12H14N2O/c1-9(15)13-7-6-10-8-14-12-5-3-2-4-11(10)12/h2-5,8,14H,6-7H2,1H3,(H,13,15)
    Key: NVUGEQAEQJTCIX-UHFFFAOYSA-N
  • CC(=O)NCCC1=CNC2=CC=CC=C21
Properties
C12H14N2O
Molar mass 202.257 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

References

edit
  1. ^ "N-Acetyltryptamine". pubchem.ncbi.nlm.nih.gov.
  2. ^ O'Brien, Paul (2 December 2012). Pineal and Retinal Relationships. Elsevier. p. 159. ISBN 978-0-323-14985-3.
  3. ^ Current Trends in Comparative Endocrinology: Proceedings of the Ninth International Symposium on Comparative Endocrinology, Hong Kong, 7-11 December 1981. Kent State University Press. ISBN 978-962-209-116-0.
  4. ^ Zhang, Wenjuan; Wei, Shaopeng; Zhang, Jiwen; Wu, Wenjun (1 March 2013). "Antibacterial Activity Composition of the Fermentation Broth of Streptomyces djakartensis NW35". Molecules. 18 (3): 2763–2768. doi:10.3390/molecules18032763. PMC 6270429.
  5. ^ Paley, Elena L. (8 October 2020). Protein Biosynthesis Interference in Disease. Academic Press. p. 94. ISBN 978-0-12-823486-0.

Further reading

edit
  • Houlihan, William J. (15 September 2009). Indoles, Volume 25, Part 2. John Wiley & Sons. p. 25. ISBN 978-0-470-18841-5.